MedTrace Logo

High Concentration Oxygen Therapy for Pneumocephalus in Chronic Subdural Haematoma: A Prospective Observational Study

NCT05143216 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2022-07-28

No results posted yet for this study

Summary

Normobaric oxygen therapy was shown to be effective in reducing post craniotomy pneumocephalus. Theoretical assessment of normobaric oxygen therapy in treating pneumocephalus has shown that a higher level of oxygen concentration will significantly decrease the time for absorption of pneumocephalus. The therapeutic efficacy is not fully established in patients with chronic subdural hematoma after burr hole drainage. Both radiological outcomes and clinical outcomes would be evaluated.

Conditions

  • Chronic Subdural Hematoma

Interventions

OTHER

Low concentration oxygen group: Room air (0-2Litre Oxygen via Nasal Canula)

Low concentration oxygen group: Room air (0-2Litre Oxygen via Nasal Cannula)

OTHER

High concentration oxygen group: Room air (12-15Litre Oxygen via Non-rebreather Mask)

High concentration oxygen group: Room air (12-15Litre Oxygen via Non-rebreather Mask)

Sponsors & Collaborators

  • Dr. David Yuen Chung CHAN

    lead OTHER

Principal Investigators

  • David YC CHAN · Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-06
Primary Completion
2022-12-30
Completion
2023-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05143216 on ClinicalTrials.gov